EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Utility of DNA Methylation as a Biomarker in Aging and Alzheimer’s Disease

Lidija Milicic, Tenielle Porter, Michael Vacher, Simon M Laws

Journal of Alzheimer's Disease Reports · 01.11.2023 · 7 (1) · 475-503

DOI: 10.3233/adr-220109 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer's Disease Reports, online erschienen am 15.05.2023. Verfasst von Lidija Milicic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic mechanisms such as DNA methylation have been implicated in a number of diseases including cancer, heart disease, autoimmune disorders, and neurodegenerative diseases. While it is recognized that DNA methylation is tissue-specific, a limitation for many studies is the ability to sample the tissue of interest, which is why there is a need for a proxy tissue such as blood, that is reflective of the methylation state of the target tissue. In the last decade, DNA methylation has been utilized in the design of epigenetic clocks, which aim to predict an individual’s biological age based on an algorithmically defined set of CpGs. A number of studies have found associations between disease and/or disease risk with increased biological age, adding weight to the theory of increased biological age being linked with disease processes. Hence, this review takes a closer look at the utility of DNA methylation as a biomarker in aging and disease, with a particular focus on Alzheimer’s disease.

Schlagwörter

Stichwörter der Autor:innen

AgingAlzheimer’s diseaseDNA methylationdementiaepigenetics

Autor:innen und Institutionen

  • Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Collaborative Genomics and Translation Group, Edith Cowan University, Joondalup, Western Australia, Australia.
  • School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.
  • CSIRO Health and Biosecurity, Australian e-Health Research Centre, Floreat, Western Australia.

Zitieren

APA

Milicic, L., Porter, T., Vacher, M., & Laws, S. M. (2023). Utility of DNA Methylation as a Biomarker in Aging and Alzheimer’s Disease. Journal of Alzheimer's Disease Reports, 7(1), 475-503. https://doi.org/10.3233/adr-220109

Vancouver

Milicic L, Porter T, Vacher M, Laws SM. Utility of DNA Methylation as a Biomarker in Aging and Alzheimer’s Disease. Journal of Alzheimer's Disease Reports. 2023;7(1):475-503. doi:10.3233/adr-220109

BibTeX
@article{Milicic2023,
  author = {Milicic, Lidija and Porter, Tenielle and Vacher, Michael and Laws, Simon M},
  title = {Utility of DNA Methylation as a Biomarker in Aging and Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease Reports},
  year = {2023},
  volume = {7},
  number = {1},
  pages = {475--503},
  doi = {10.3233/adr-220109}
}
Kostenlos starten →